Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salbutamol as Adjuvant Therapy for Pompe Disease
NCT02405598Phase 4Completed
- Sponsor
- National Taiwan University Hospital
- Start
- Oct 2013
- Primary completion
- Jul 2015
- Countries
- 1
01
Overview
A Phase 4 trial of salbutamol in Pompe disease, sponsored by National Taiwan University Hospital. Started Oct 2013; status: completed.
02
Drugs
salbutamol
03
Conditions
Pompe disease
Beyond the preview
Go deeper on NCT02405598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02405598.